<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Evaluation | Nano Publications</title>
	<atom:link href="https://bibliography.nanobiotix.com/tag/evaluation/feed/" rel="self" type="application/rss+xml" />
	<link>https://bibliography.nanobiotix.com</link>
	<description>Navigate through all Nanobiotix publications online</description>
	<lastBuildDate>Tue, 24 May 2022 09:42:29 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.0</generator>

<image>
	<url>https://bibliography.nanobiotix.com/wp-content/uploads/2019/11/cropped-n-icon-512x512-32x32.png</url>
	<title>Evaluation | Nano Publications</title>
	<link>https://bibliography.nanobiotix.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>2017 – AACR Abstract – NBTXR3 anti-tumor efficacy in vivo</title>
		<link>https://bibliography.nanobiotix.com/2017-aacr-abstract-nbtxr3-anti-tumor-efficacy-in-vivo/</link>
					<comments>https://bibliography.nanobiotix.com/2017-aacr-abstract-nbtxr3-anti-tumor-efficacy-in-vivo/#respond</comments>
		
		<dc:creator><![CDATA[nano-pub]]></dc:creator>
		<pubDate>Wed, 01 Mar 2017 10:02:48 +0000</pubDate>
				<category><![CDATA[Congress Abstracts]]></category>
		<category><![CDATA[In Vitro in Vivo NBTXR3]]></category>
		<category><![CDATA[In Vivo]]></category>
		<category><![CDATA[Administration]]></category>
		<category><![CDATA[Density]]></category>
		<category><![CDATA[Dose]]></category>
		<category><![CDATA[Electron]]></category>
		<category><![CDATA[Evaluation]]></category>
		<category><![CDATA[Hafnium Oxide]]></category>
		<category><![CDATA[Head & Neck]]></category>
		<category><![CDATA[Intratumor]]></category>
		<category><![CDATA[Radiation]]></category>
		<category><![CDATA[Radiotherapy]]></category>
		<category><![CDATA[Tomography]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[Tumor]]></category>
		<guid isPermaLink="false">http://bibliography.nanobiotix.com/?p=683</guid>

					<description><![CDATA[<p>NBTXR3 has been evaluated in numerous in vivo models. The antitumor efficacy was systematically enhanced in terms of tumor growth delay for animals treated with NBTXR3 and exposed to radiotherapy when compared to radiotherapy alone. In this abstract the transferability of the treatment with NBTXR3 from one type of cancer to the other is described.</p>
<p>NBTXR3 is intended to be injected in the tumors. Spilling in the circulation may occur during product administration or, as expected, during tumor destruction, leading to steady trapping of NPs in the reticulo-endothelial system (liver and spleen). Clinically, it is unknown whether patients, previously treated with NPs, may show toxic signs when NPs are exposed (activation) to diagnosis imaging (computed tomography(CT)) of the liver.</p>
The post <a href="https://bibliography.nanobiotix.com/2017-aacr-abstract-nbtxr3-anti-tumor-efficacy-in-vivo/">2017 – AACR Abstract – NBTXR3 anti-tumor efficacy in vivo</a> first appeared on <a href="https://bibliography.nanobiotix.com">Nano Publications</a>.]]></description>
										<content:encoded><![CDATA[<div class="az-main-section-content az-module az-padding-top-0 az-padding-bottom-0 az-section-default az-section-with-equal no-animate-content az-module-bg-color">
        <div class="az-module-wrap-bg">
            <div class="az-module-wrapper-bg" style="background: #28282e;"></div>
            
        </div><div class="container-fluid az-container-no-padding"><div class="row row-parent az-gutter-0 az-equal"><div class="single-clms col-md-12 az-main-col-content az-module az-v-space-clm no-animate-content az-module-default"><div class="az-col az-clm-padding-0" ><div class="az-col-cont"><div class="row row-inner az-padding-top-0 az-padding-bottom-0 az-gutter-0 az-equal no-animate-content"><div data-animation-type="ani-in" data-animation-in="fadeInUp" data-animation-out="none" data-animation-speed="default" data-animation-delay="200" data-offset-down="90" data-offset-up="none" class="single-clms col-md-6 az-main-col-content az-module az-col-pos-middle az-v-space-clm animate-content az-module-bg-image"><div class="az-col az-clm-padding-105" data-col-min-height-default="700" data-col-min-height-sm="400" data-col-min-height-xs="350" style="min-height: 700px;">
        <div class="az-module-wrap-bg">
            <div class="az-module-wrapper-bg  az-imagesLoadedBg" style="background-image: url(https://bibliography.nanobiotix.com/wp-content/uploads/2017/02/Working-it.jpg); background-position: center center; background-repeat: no-repeat; background-size: cover;">
            
    <div class="az-module-mask-group">
        <span class="az-module-mask-bg is-bg main-mask"></span>
        
    </div>
            </div>
            
        </div><div class="az-col-cont"><div class="az-content-element-wrapper az-empty-divider hidden-lg hidden-md" style="height: 60px;"></div>
<div class="az-content-element-wrapper az-box-icon-wrapper az-margin-top-0 az-margin-bottom-0 no-animate-content">
    <div class="az-box-icon az-box-icon-top">
            <div class="az-icon-container" style="color: #ffffff; font-size: 50px;"><i class="fa fa-edit"></i>
            </div><div class="az-box-icon-content az-font-custom az-font-color-custom" style="color: #ffffff;"><h3 class="az-box-icon-title">Authors</h3><p>Ping Zhang, Sonia Vivet, Sébastien Paris, Agnès Pottier<br />
<span class="notes">Nanobiotix, Paris, France</span></p>
</div></div>
</div>
<div class="az-content-element-wrapper az-empty-divider hidden-lg hidden-md" style="height: 60px;"></div></div></div></div><div data-animation-type="ani-in" data-animation-in="fadeInUp" data-animation-out="none" data-animation-speed="default" data-animation-delay="300" data-offset-down="90" data-offset-up="none" class="single-clms col-md-6 az-main-col-content az-module az-col-pos-middle az-v-space-clm animate-content az-module-bg-color"><div class="az-col az-clm-padding-105" >
        <div class="az-module-wrap-bg">
            <div class="az-module-wrapper-bg" style="background: #ffffff;"></div>
            
        </div><div class="az-col-cont"><div class="az-content-element-wrapper az-empty-divider hidden-lg hidden-md" style="height: 60px;"></div>
<div class="az-content-element-wrapper az-box-icon-wrapper az-margin-top-0 az-margin-bottom-0 no-animate-content">
    <div class="az-box-icon az-box-icon-top">
            <div class="az-icon-container" style="color: #28282e; font-size: 50px;"><i class="az-icon az-icon-layers2"></i>
            </div><div class="az-box-icon-content"><h3 class="az-box-icon-title">Summary</h3><p>NBTXR3 has been evaluated in numerous <em>in vivo</em> models. The antitumor efficacy was systematically enhanced in terms of tumor growth delay for animals treated with NBTXR3 and exposed to radiotherapy when compared to radiotherapy alone. In this abstract the transferability of the treatment with NBTXR3 from one type of cancer to the other is described.</p>
</div></div>
</div>
<div class="az-content-element-wrapper az-empty-divider hidden-lg hidden-md" style="height: 60px;"></div></div></div></div></div></div></div></div></div></div></div>The post <a href="https://bibliography.nanobiotix.com/2017-aacr-abstract-nbtxr3-anti-tumor-efficacy-in-vivo/">2017 – AACR Abstract – NBTXR3 anti-tumor efficacy in vivo</a> first appeared on <a href="https://bibliography.nanobiotix.com">Nano Publications</a>.]]></content:encoded>
					
					<wfw:commentRss>https://bibliography.nanobiotix.com/2017-aacr-abstract-nbtxr3-anti-tumor-efficacy-in-vivo/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>2010 &#8211; CLINAM Abstract &#8211; Expected and Unexpected Side Effects of Nanodrugs &#8211; Levy et al.</title>
		<link>https://bibliography.nanobiotix.com/2010-clinam-abstract-expected-and-unexpected-side-effects-of-nanodrugs-levy-et-al/</link>
					<comments>https://bibliography.nanobiotix.com/2010-clinam-abstract-expected-and-unexpected-side-effects-of-nanodrugs-levy-et-al/#respond</comments>
		
		<dc:creator><![CDATA[nano-pub]]></dc:creator>
		<pubDate>Tue, 07 Feb 2017 17:03:38 +0000</pubDate>
				<category><![CDATA[Congress Abstracts]]></category>
		<category><![CDATA[Miscellaneous]]></category>
		<category><![CDATA[Aggregation]]></category>
		<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Evaluation]]></category>
		<category><![CDATA[Impact]]></category>
		<category><![CDATA[Safety]]></category>
		<category><![CDATA[Stability]]></category>
		<guid isPermaLink="false">http://localhost:8888/nano-publications/?p=236</guid>

					<description><![CDATA[<p>Nanotechnology offers revolutionary strategies to improve healthcare. Adequate nanomaterial characterization constitutes the basis to establish relevant programs of nanoparticle/biological systems cross talk evaluation. Also, the surrounding conditions significantly impact on the state of the nanoparticles in terms of their collective behavior: dispersion, aggregation, and stability in gas or liquid.</p>
The post <a href="https://bibliography.nanobiotix.com/2010-clinam-abstract-expected-and-unexpected-side-effects-of-nanodrugs-levy-et-al/">2010 – CLINAM Abstract – Expected and Unexpected Side Effects of Nanodrugs – Levy et al.</a> first appeared on <a href="https://bibliography.nanobiotix.com">Nano Publications</a>.]]></description>
										<content:encoded><![CDATA[<div class="az-main-section-content az-module az-padding-top-0 az-padding-bottom-0 az-section-default az-section-with-equal no-animate-content az-module-bg-color">
        <div class="az-module-wrap-bg">
            <div class="az-module-wrapper-bg" style="background: #28282e;"></div>
            
        </div><div class="container-fluid az-container-no-padding"><div class="row row-parent az-gutter-0 az-equal"><div class="single-clms col-md-12 az-main-col-content az-module az-v-space-clm no-animate-content az-module-default"><div class="az-col az-clm-padding-0" ><div class="az-col-cont"><div class="row row-inner az-padding-top-0 az-padding-bottom-0 az-gutter-0 az-equal no-animate-content"><div data-animation-type="ani-in" data-animation-in="fadeInUp" data-animation-out="none" data-animation-speed="default" data-animation-delay="200" data-offset-down="90" data-offset-up="none" class="single-clms col-md-6 az-main-col-content az-module az-col-pos-middle az-v-space-clm animate-content az-module-bg-image"><div class="az-col az-clm-padding-105" data-col-min-height-default="700" data-col-min-height-sm="400" data-col-min-height-xs="350" style="min-height: 700px;">
        <div class="az-module-wrap-bg">
            <div class="az-module-wrapper-bg  az-imagesLoadedBg" style="background-image: url(https://bibliography.nanobiotix.com/wp-content/uploads/2017/02/Author.jpg); background-position: center center; background-repeat: no-repeat; background-size: cover;">
            
    <div class="az-module-mask-group">
        <span class="az-module-mask-bg is-bg main-mask"></span>
        
    </div>
            </div>
            
        </div><div class="az-col-cont"><div class="az-content-element-wrapper az-empty-divider hidden-lg hidden-md" style="height: 60px;"></div>
<div class="az-content-element-wrapper az-box-icon-wrapper az-margin-top-0 az-margin-bottom-0 no-animate-content">
    <div class="az-box-icon az-box-icon-top">
            <div class="az-icon-container" style="color: #ffffff; font-size: 50px;"><i class="fa fa-edit"></i>
            </div><div class="az-box-icon-content az-font-custom az-font-color-custom" style="color: #ffffff;"><h3 class="az-box-icon-title">Authors</h3><p>Dr. Laurent Lévy, CEO of Nanobiotix, and Co-President of the French Technology Platform on<br />
Nanomedicine (FTPN), Paris (F)</p>
</div></div>
</div>
<div class="az-content-element-wrapper az-empty-divider hidden-lg hidden-md" style="height: 60px;"></div></div></div></div><div data-animation-type="ani-in" data-animation-in="fadeInUp" data-animation-out="none" data-animation-speed="default" data-animation-delay="300" data-offset-down="90" data-offset-up="none" class="single-clms col-md-6 az-main-col-content az-module az-col-pos-middle az-v-space-clm animate-content az-module-bg-color"><div class="az-col az-clm-padding-105" >
        <div class="az-module-wrap-bg">
            <div class="az-module-wrapper-bg" style="background: #ffffff;"></div>
            
        </div><div class="az-col-cont"><div class="az-content-element-wrapper az-empty-divider hidden-lg hidden-md" style="height: 60px;"></div>
<div class="az-content-element-wrapper az-box-icon-wrapper az-margin-top-0 az-margin-bottom-0 no-animate-content">
    <div class="az-box-icon az-box-icon-top">
            <div class="az-icon-container" style="color: #28282e; font-size: 50px;"><i class="az-icon az-icon-layers2"></i>
            </div><div class="az-box-icon-content"><h3 class="az-box-icon-title">Summary</h3><p>Nanotechnology offers revolutionary strategies to improve healthcare. Adequate nanomaterial characterization constitutes the basis to establish relevant programs of nanoparticle/biological systems cross talk evaluation. Also, the surrounding conditions significantly impact on the state of the nanoparticles in terms of their collective behavior: dispersion, aggregation, and stability in gas or liquid.</p>
<p>The “principle of designing” specific products is the paradigm of the nanomedecine. It is really new and it represents an essential point since creating innovative products should be supported by a previous risk evaluation based on the nanoscale chemistry. Furthermore, size does matter. Thus, both, size and chemistry of nanoparticles are probably the fundamental parameters from which all others depend on, and ultimately nanomaterial surface. And surfaces are the key players when considering safety. </p>
</div></div>
</div>
<div class="az-content-element-wrapper az-empty-divider hidden-lg hidden-md" style="height: 60px;"></div></div></div></div></div></div></div></div></div></div></div>The post <a href="https://bibliography.nanobiotix.com/2010-clinam-abstract-expected-and-unexpected-side-effects-of-nanodrugs-levy-et-al/">2010 – CLINAM Abstract – Expected and Unexpected Side Effects of Nanodrugs – Levy et al.</a> first appeared on <a href="https://bibliography.nanobiotix.com">Nano Publications</a>.]]></content:encoded>
					
					<wfw:commentRss>https://bibliography.nanobiotix.com/2010-clinam-abstract-expected-and-unexpected-side-effects-of-nanodrugs-levy-et-al/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
